Author:
Yockman J W,Kim W J,Chang C-W,Kim S W
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference29 articles.
1. Sternberg CN . Metastatic renal cell cancer treatments. Drugs Today (Barc) 2003; 39 (Suppl C): 39–59.
2. Fisher RI, Rosenberg SA, Fyfe G . Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. Cancer J Sci Am 2000; 6 (Suppl 1): S55–S57.
3. Robson CJ, Churchill BM, Anderson W . The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301.
4. McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 2005; 23: 133–141.
5. Mier JW, Aronson FR, Numerof RP, Vachino G, Atkins MB . Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells. Pathol Immunopathol Res 1988; 7: 459–476.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献